Health News Review
  • Jun 6 2013

    False claims about colonoscopy in response to NYT story

    The following is a guest post by Dr. Richard Hoffman, one of our expert editors on ————————– The New York Times story, “The $2.7 Trillion Medical Bill: Colonoscopies Explain Why U.S. Leads the World in Health Expenditures,” about how the exorbitant costs associated with colonoscopy contribute to the high costs of American medicine has [...]

  • Jun 1 2013

    “Here they go again” – 3 new proton beam facilities w/in 40 miles in DC-Baltimore

    “When it comes to reining in health care spending, it still seems like each hospital administrator thinks the guy at the other hospital should do it.”  That was the lead, as Jenny Gold of Kaiser Health News reports that two Washington,DC hospitals – three miles apart – are building expensive proton beam radiation centers for [...]

  • May 27 2013

    Breast Cancer Action Webinar – Separating Hype from Hope: Breast Cancer Media Literacy

    Breast Cancer Action asked me to join them for a webinar Wed. May 29 and Thurs. May 30.  I’ll make a presentation and answer questions, as will Mandy Stahre, PhD, one of our story reviewers on  Mandy is perfect for this role because she’s very smart – earning her PhD in epidemiology at the [...]

    No Comments
  • May 21 2013

    IMRT for prostate cancer: newer, costlier radiation no better than old

    HealthDay reports on a paper published in JAMA Internal Medicine: “The costly form of radiation therapy that has become the norm for prostate cancer in the United States may be no better than the older, cheaper variety — at least for some men, a new study suggests. Researchers found that among more than 1,000 U.S. [...]

    1 Comment
  • May 17 2013

    Here we go again: early news on early abstract release from ASCO

    The following is a guest post by Harold DeMonaco, MS, one of our expert reviewers on, and a frequent guest blogger on this site. ———————- The American Society of Clinical Oncology (ASCO) will hold its annual meeting starting on May 31st in Chicago, Illinois.  While we have consistently cautioned against over reading the abstracts [...]

    1 Comment
  • May 14 2013

    When news like Angelina Jolie’s occurs, I learn from other breast cancer experts

    Women with breast cancer who are active on social media make a vital contribution to our public dialogue. So, when I read Angelina Jolie’s New York Times opinion piece, “My Medical Choice,” about her decision to have bilateral prophylactic mastectomy after breast cancer gene testing, I turned to some of the women I follow through [...]

    1 Comment
  • May 13 2013

    Barbara Brenner (1951-2013) “Social justice activist. Corporate ass-kicker. Civil rights advocate. Profound changer of lives.”

    That’s the way Barbara is described on the website of Breast Cancer Action, which she ran until 2010 when she stepped down because of her ALS diagnosis. She died last Friday. You can read more on their site.  But I chose this key excerpt: “One of the most successful – and controversial – of the [...]

  • May 3 2013

    “Radical change” – American Urological Association stops recommending routine PSA tests

    On Twitter, Liz Szabo of USA Today asks, “Is this the end of the PSA?” She was referring to new clinical guidelines released by the American Urological Association. She reported: “In a major break from the past, a leading medical group is advising men to think carefully before getting getting screened for prostate cancer. The [...]

  • Apr 25 2013

    Two noteworthy breast cancer stories: “The Feel-Good War” and guidelines didn’t change practice

    The New York Times Sunday magazine piece, “Our Feel-Good War on Breast Cancer,” is by Peggy Orenstein who begins: “I used to believe that a mammogram saved my life. I even wrote that in the pages of this magazine. It was 1996, and I had just turned 35 when my doctor sent me for an [...]

    1 Comment
  • Apr 10 2013

    Men’s Health feature: The $6 Million Dollar Gland

    Jim Thornton’s story is about prostate cancer screening.  The six million dollar figure refers to the cost of screening for and treating prostate cancer.  Excerpt: “At $1,000 or more per biopsy, the cost to U.S. health care for prostate biopsies alone is estimated to run into the billions each year. Whenever cancer is found, expenses [...]

    1 Comment